Table 3.
Clinical outcomes
| Sepsis (n = 1946) | No sepsis (n = 6024) | |||||||
|---|---|---|---|---|---|---|---|---|
| No AKI (n = 628) | Stage 1 (n = 575) | Stage 2 (n = 219) | Stage 3 (n = 524) | No AKI (n = 2615) | Stage 1 (n = 1976) | Stage 2 (n = 627) | Stage 3 (n = 806) | |
| ICU LOS (days), median (IQR) | 7 (2–22)b | 7 (3–29)b | 8 (4–54)ab | 19 (6–60)ab | 3 (1–5) | 3 (2–5) | 2 (1–6)a | 4 (2–60)a |
| Hospital LOS (days), median (IQR) | 25 (12–60)b | 28 (13–60)b | 49 (14–60)ab | 60 (22–60)ab | 10 (6–22) | 10 (6–24) | 11 (6–35)a | 20 (7–60)a |
| RRT, n (%) | 25 (4.0)b | 33 (5.7)b | 15 (6.8)b | 307 (58.6)ab | 27 (1.0) | 22 (1.1) | 10 (1.6) | 267 (33.1)a |
| ICU mortality, n (%) | 108 (17.6)b | 117 (20.6)ab | 50 (23.5)ab | 216 (41.5)ab | 213 (8.4) | 138 (7.2) | 76 (12.4)a | 228 (29.2)a |
| Hospital mortality, n (%) | 154 (25.9)b | 162 (29.3)ab | 74 (35.6)ab | 261 (51.7)ab | 286 (11.8) | 219 (11.9) | 102 (17.4)a | 262 (34.6)a |
AKI acute kidney injury, ICU intensive care unit, LOS length of stay, IQR interquartile range, RRT renal replacement therapy, n number of patients
aSignificant at 5% level vs No AKI in the same group (sepsis or no sepsis)
bSignificant at 5% level vs no sepsis patients with the same AKIN stage